Note 6 - Stock-based Awards: | NOTE 6 – STOCK-BASED AWARDS: During the year ended September 30, 2021, the Company’s shareholders approved an increase to the number of shares of common stock reserved for issuance under the Plan to 15,000,000 shares of common stock, including 10,000,000 shares of common stock reserved for incentive stock options. Upon exercise of options or other awards, shares are issued from the available authorized shares of the Company. Option awards are granted with an exercise price equal to the trading price of the Company’s stock at the date of grant. On October 8, 2020, the Company granted a total of 1,100,000 options to purchase shares of the Company’s common stock that expire in five years with an exercise price of $0.25 in conjunction with the appointment of officers and a director. These granted options had a total fair value of $260,000. These options vested immediately, with the exception of 187,500 options vesting at each of the following three grant anniversary dates, with a fair value of $44,321 being expensed to share-based compensation, respectively. On May 6, 2021, the Company granted a total of 2,785,000 options to employees, consultants, officers and directors to purchase shares of the Company’s common stock that expire in five years with an exercise price of $0.25. These granted options had a total fair value of $519,400. All options vested upon grant. The fair value of the option awards granted and vested during the three months ended December 31, 2021 and 2020 was $nil and $127,021, respectively. The fair value of unvested options will be recognized as compensation in the amount of $44,321 at each of the following three grant anniversary dates. Fair values of options issued were measured on the date of the grant with a Black-Scholes option-pricing model using the assumptions noted in the following table: Options Granted at May 6, 2021 Options Granted at October 8, 2020 Expected volatility 167.9% 171.9% Stock price on date of grant $0.20 $0.25 Exercise price $0.25 $0.25 Expected dividends - - Expected term (in years) 5 5 Risk-free rate 0.05% 0.09% Expected forfeiture rate 0% 0% The following is a summary of options issued and outstanding: Options Weighted Average Exercise Price Outstanding at September 30, 2020 5,400,000 0.16 Granted 3,885,000 0.12 Expired (950,000) (0.43) Outstanding at September 30, 2021 8,335,000 $ 0.18 Granted - - Expired - - Outstanding at December 31, 2021 8,335,000 0.18 Outstanding and exercisable at December 31, 2021 7,960,000 $ 0.17 Weighted average remaining contractual term (years) 3.04 The aggregate of options exercisable as of December 31, 2021 had an intrinsic value of $428,500 for both outstanding and vested options, based on the closing price of $0.21 per share of the Company’s common stock on December 31, 2021. |